Clinical Trials
3
Active:1
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Safety and Efficacy Study of A0001 in Patients With the A3243G Mitochondrial DNA Point Mutation
Phase 2
Terminated
- Conditions
- Neuromuscular Disease
- Interventions
- Drug: A0001 (alpha-tocopherolquinone)Drug: Placebo
- First Posted Date
- 2010-02-24
- Last Posted Date
- 2011-04-22
- Lead Sponsor
- Penwest Pharmaceuticals Co.
- Target Recruit Count
- 30
- Registration Number
- NCT01074359
- Locations
- 🇬🇧
University of Newcastle upon Tyne, Newcastle, Framlington Place, United Kingdom
Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
Phase 2
Completed
- Conditions
- Friedreich's Ataxia
- Interventions
- Drug: placebo
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2011-04-22
- Lead Sponsor
- Penwest Pharmaceuticals Co.
- Target Recruit Count
- 42
- Registration Number
- NCT01035671
- Locations
- 🇺🇸
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
News
No news found